metergoline has been researched along with fluvoxamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
Horiuchi, H; Morino, T; Ogata, T; Takeba, J; Yamamoto, H | 1 |
2 other study(ies) available for metergoline and fluvoxamine
Article | Year |
---|---|
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Serotonergic signaling inhibits hyperalgesia induced by spinal cord damage.
Topics: Animals; Brain Stem; Female; Fluvoxamine; Hot Temperature; Hyperalgesia; Metergoline; Nociceptors; Pain Measurement; Physical Stimulation; Rats; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Signal Transduction; Spinal Cord; Spinal Cord Compression; Spinal Cord Injuries | 2003 |